Atezolizumab in non-squamous non-small cell lung cancer

被引：5
|
作者：
Akamine, Takaki [1 ]
Toyokawa, Gouji [1 ]
Tagawa, Tetsuzo [1 ]
Seto, Takashi [2 ]
机构：
[1] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan
[2] Kyushu Natl Canc Ctr, Dept Thorac Oncol, Minami Ku, Fukuoka, Fukuoka, Japan
来源：
JOURNAL OF THORACIC DISEASE | 2018年 / 10卷
关键词：
OPEN-LABEL; 1ST-LINE THERAPY; PHASE-2; TRIAL; EGFR; IMMUNOTHERAPY; PEMBROLIZUMAB; MULTICENTER; BEVACIZUMAB; CHEMOTHERAPY; DOCETAXEL;
D O I：
10.21037/jtd.2018.07.92
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：S3155 / S3159
页数：5
相关论文
共 50 条
  • [31] Pemetrexed A Review of its Use in the Management of Advanced Non-Squamous Non-Small Cell Lung Cancer
    Baldwin, Claudine M.
    Perry, Caroline M.
    DRUGS, 2009, 69 (16) : 2279 - 2302
  • [32] Smoking History as a Predictor of Pemetrexed Monotherapy in Patients with Non-Squamous Non-Small Cell Lung Cancer
    Igawa, Satoshi
    Sasaki, Jiichiro
    Otani, Sakiko
    Shirasawa, Masayuki
    Niwa, Hideyuki
    Kusuhara, Seiichiro
    Harada, Shinya
    Kubota, Masaru
    Katagiri, Masato
    Masuda, Noriyuki
    ONCOLOGY, 2016, 91 (01) : 41 - 47
  • [33] Expanded molecular interrogation for potential actionable targets in non-squamous non-small cell lung cancer
    Lau, Kah Weng
    Seng, Claudia
    Lim, Tony K. H.
    Tan, Daniel S. W.
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (18)
  • [34] MOLECULAR TESTING IN NON-SQUAMOUS NON-SMALL CELL LUNG CANCER AND THE ROLE OF LIQUID CYTOLOGY SPECIMENS
    Moore, S.
    Loff, K.
    Murphy, M.
    RESPIROLOGY, 2020, 25 : 60 - 60
  • [35] EFFECTIVENESS AND TOLERANCE OF MAINTENANCE THERAPY IN PATIENTS WITH NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)
    Santos, E. S.
    Belalcazar, A.
    Vazquez, A.
    Gomez, J. E.
    Raez, L. E.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S97 - S97
  • [36] EGFR mutations and gefitinib sensitivity in patients with metastatic non-squamous non-small cell lung cancer
    Moiseyenko, V.
    Imyanitov, E.
    Levchenko, E.
    Procenko, S.
    Orlova, R.
    Iyevleva, A.
    Buslov, K.
    Ulibina, Y.
    Matsko, D.
    Moiseyenko, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [37] Prognostic value of Beclin 1, EGFR and ALK in non-squamous non-small cell lung cancer
    Wan, Yanhui
    Qian, Youhui
    Wang, Youyu
    Fang, Fuyuan
    Wu, Guodong
    DISCOVER ONCOLOGY, 2022, 13 (01)
  • [38] Efficacy and safety of bevacizumab in the treatment of advanced, non-squamous non-small cell lung cancer (NSCLC)
    Tassinari, D.
    Drudi, F.
    Carloni, F.
    Nicoletti, S.
    Possenti, C.
    Santelmo, C.
    Lazzari, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [39] Phase II study of atezolizumab with bevacizumab for non-squamous non-small cell lung cancer with high PD-L1 expression (@Be Study)
    Seto, Takashi
    Nosaki, Kaname
    Shimokawa, Mototsugu
    Toyozawa, Ryo
    Sugawara, Shunichi
    Hayashi, Hidetoshi
    Murakami, Haruyasu
    Kato, Terufumi
    Niho, Seiji
    Saka, Hideo
    Oki, Masahide
    Yoshioka, Hiroshige
    Okamoto, Isamu
    Daga, Haruko
    Azuma, Koichi
    Tanaka, Hiroshi
    Nishino, Kazumi
    Tohnai, Rie
    Yamamoto, Nobuyuki
    Nakagawa, Kazuhiko
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (02)
  • [40] Cost-Effectiveness Analysis of Atezolizumab Plus Chemotherapy in the First-Line Treatment of Metastatic Non-Squamous Non-Small Cell Lung Cancer
    Ding, Dong
    Hu, Huabin
    Liao, Mengting
    Shi, Yin
    She, Longjiang
    Yao, Linli
    Zhu, Youwen
    Zeng, Shan
    Huang, Jin
    ADVANCES IN THERAPY, 2020, 37 (05) : 2116 - 2126
12345